Healthlead PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Jan '21 Jan 1, 2021
Operating Revenue	2,190	1,977	1,636	1,520	1,199	1,064
Other Revenue	41.26	34.35	23.77	18.69	17.62	15.91
Revenue	2,232	2,011	1,659	1,538	1,216	1,080
Revenue Growth (YoY)	16.03%	21.22%	7.87%	26.46%	12.63%	15.51%
Cost of Revenue	1,661	1,512	1,258	1,143	922.42	831.18
Gross Profit	570.11	499.1	400.98	394.95	293.95	248.81
Selling, General & Admin	467.87	410.04	306.94	249.52	191.31	175.4
Other Operating Expenses	-8.14	-6.33	-6.68	-2.97	-	-
Operating Expenses	459.73	403.71	300.26	246.55	191.31	175.4
Operating Income	110.38	95.39	100.72	148.39	102.64	73.41
Interest Expense	-16.36	-13.61	-8.98	-5.73	-5.34	-6.99
Interest & Investment Income	5.61	8.02	2.87	0.17	0.04	0.11
EBT Excluding Unusual Items	99.31	89.79	94.61	142.83	97.35	66.54
Gain (Loss) on Sale of Assets	-	6.45	-	-	-	-
Asset Writedown	0.21	0.21	-0.57	-	-	-
Pretax Income	99.52	96.46	94.04	142.83	97.35	66.54
Income Tax Expense	18.29	18.19	19.36	24.61	17.68	14.46
Net Income	81.23	78.26	74.68	118.23	79.66	52.08
Net Income to Common	81.23	78.26	74.68	118.23	79.66	52.08
Net Income Growth	5.80%	4.80%	-36.84%	48.41%	52.98%	139.25%
Shares Outstanding (Basic)	270	272	272	272	206	162
Shares Outstanding (Diluted)	270	272	272	272	206	162
Shares Change (YoY)	-0.62%	-	-	31.84%	27.46%	1.16%
EPS (Basic)	0.30	0.29	0.27	0.43	0.39	0.32
EPS (Diluted)	0.30	0.29	0.27	0.43	0.39	0.32
EPS Growth	6.46%	4.80%	-36.84%	12.57%	20.02%	136.50%
Free Cash Flow	117.33	14.2	9.72	16.07	72.44	83.56
Free Cash Flow Per Share	0.43	0.05	0.04	0.06	0.35	0.52
Dividend Per Share	0.170	0.170	0.150	0.180	0.280	0.070
Dividend Growth	13.33%	13.33%	-16.67%	-35.71%	300.00%	-
Gross Margin	25.55%	24.81%	24.16%	25.68%	24.17%	23.04%
Operating Margin	4.95%	4.74%	6.07%	9.65%	8.44%	6.80%
Profit Margin	3.64%	3.89%	4.50%	7.69%	6.55%	4.82%
Free Cash Flow Margin	5.26%	0.71%	0.59%	1.04%	5.96%	7.74%
EBITDA	159.17	131.3	126.32	162.96	117.12	80.15
EBITDA Margin	7.13%	6.53%	7.61%	10.59%	9.63%	7.42%
D&A For EBITDA	48.79	35.92	25.6	14.57	14.48	6.74
EBIT	110.38	95.39	100.72	148.39	102.64	73.41
EBIT Margin	4.95%	4.74%	6.07%	9.65%	8.44%	6.80%
Effective Tax Rate	18.38%	18.86%	20.58%	17.23%	18.16%	21.73%
Revenue as Reported	2,018	2,018	1,659	1,538	1,216	1,080

Source: S&P Global Market Intelligence. Standard template. Financial Sources.